CJC-1295/IpamorelinGrowth-hormone support for recovery, body composition, and restorative sleep.Hover, focus, or tap for detailsTap for details
CJC-1295 and Ipamorelin are presented as a complementary peptide combination that supports the body’s own growth-hormone signaling. The treatment page describes Ipamorelin as a selective growth-hormone secretagogue that prompts pituitary release, while the combination is intended to create a more sustained pattern that resembles natural growth-hormone secretion.
In a provider-guided plan, this combination may be considered for goals related to lean muscle support, fat metabolism, recovery and repair, sleep quality, and overall vitality. The approved treatment page also discusses cardiovascular, bone-density, immune, skin-elasticity, and healthy-aging support. Individual response and appropriateness depend on health history and treatment goals.
Victory Select notes that the therapy is generally well tolerated when administered appropriately. Potential effects described on the individual page include injection-site redness or irritation, occasional headache, and mild nausea. A healthcare provider should review a patient’s health status before therapy and provide guidance throughout treatment to help determine whether the approach is appropriate.
Physician-guided care: Victory Select says a healthcare provider should review health status and treatment goals before therapy, then provide guidance throughout care to help determine whether this approach remains appropriate. The treatment page also describes potential effects such as redness, headache, or mild nausea.




















